TWA
NMTR

TCI Wealth Advisors’s 9 Meters Biopharma NMTR Stock Holding History

TCI Wealth Advisors’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-50
Closed -$70 – 2478
2023
Q1 		$70 Hold
50
– – ﹤0.01% 2430
2022
Q4 		$63 Buy
+50
New +$114 ﹤0.01% 2423
2022
Q3 		– Sell
-50
Closed – – 2685
2022
Q2 		$0 Buy
50
+15
+43% +$141 ﹤0.01% 2595
2022
Q1 		$0 Hold
35
– – ﹤0.01% 2545
2021
Q4 		$1K Hold
35
– – ﹤0.01% 2270
2021
Q3 		$1K Hold
35
– – ﹤0.01% 2339
2021
Q2 		$1K Sell
35
-50
-59% -$1.23K ﹤0.01% 2279
2021
Q1 		$2K Sell
85
-120
-59% -$3.69K ﹤0.01% 1966
2020
Q4 		$4K Buy
205
+80
+64% +$1.33K ﹤0.01% 1040
2020
Q3 		$2K Buy
+125
New +$1.52K ﹤0.01% 1221

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return

TCI Wealth Advisors's NMTR Position: Q2 2023 in Review

TCI Wealth Advisors sold out of 9 Meters Biopharma (NMTR) in Q2 2023, closing a stake of 50 shares — an estimated $70 sold.

TCI Wealth Advisors first reported a position in NMTR in Q3 2020 and held it in 10 quarters. The position peaked at $4K in Q4 2020. 34 funds tracked by Wall St. Rank hold NMTR as of Q2 2023.

  • TCI Wealth Advisors reported no remaining 9 Meters Biopharma position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 50 9 Meters Biopharma shares in Q2 2023, an estimated $70.
  • TCI Wealth Advisors first reported a position in 9 Meters Biopharma in Q3 2020 and held it in 10 quarters.
  • TCI Wealth Advisors's 9 Meters Biopharma position peaked at $4K in Q4 2020.
  • 34 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.